Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bellerophon Therapeutics, Inc. BLPH

Set alert

Price alert · BLPH

All alert types
0.01 +0.01 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
146.79K
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.45
Beta
0.60
Short ratio
0.39
Inst. own
44.43%
Dividend
0.00
Ex-div date
Earnings
Dec 17, 2024
50-d avg
4.34
200-d avg
3.45
1y target
2.00

6M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Jul 1, 2024Earnings: —; estimate 0; surprise —%
  • Sep 30, 2024Earnings: —; estimate 0; surprise —%
  • Dec 17, 2024Earnings: —; estimate 0; surprise —%
Signals (15)
NameDateAgo
RSI: OversoldDec 18, 20241 year ago
SMA: BearishDec 9, 20241 year ago
SMA: BearishDec 9, 20241 year ago
RSI: OversoldDec 9, 20241 year ago
MACD: Sell SignalDec 3, 20241 year ago
SMA: BullishNov 21, 20241 year ago
RSI: OverboughtNov 5, 20241 year ago
SMA: BullishOct 11, 20242 years ago
MACD: Buy SignalAug 22, 20242 years ago
MACD: Sell SignalAug 6, 20242 years ago
RSI: OversoldAug 6, 20242 years ago
MACD: Buy SignalJul 23, 20242 years ago
SMA: BearishJun 20, 20242 years ago
SMA: BearishJun 20, 20242 years ago
MACD: Sell SignalJun 20, 20242 years ago

Financial health

Altman Z-Score

-77.28 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.4×
FY 2013: -28.0×FY 2014: -26.9×FY 2015: -7.2×FY 2016: -2.5×FY 2017: -1.8×FY 2018: 18.5×FY 2019: -1.8×FY 2020: -2.1×FY 2021: -1.7×FY 2022: -0.4×
FY 2013 5y median -1.7× FY 2022
P/S 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
P/B 3.4×
FY 2013: -110×FY 2014: 69.8×FY 2015: 11.0×FY 2016: 3.3×FY 2017: -38.7×FY 2018: 13.5×FY 2019: 6.6×FY 2020: 1.4×FY 2021: 1.4×FY 2022: 3.4×
FY 2013 5y median 3.4× FY 2022
P/FCF -0.5×
FY 2013: -30.0×FY 2014: -22.7×FY 2015: -7.1×FY 2016: -3.4×FY 2017: -6.4×FY 2018: -3.4×FY 2019: -1.8×FY 2020: -2.6×FY 2021: -1.3×FY 2022: -0.5×
FY 2013 5y median -1.8× FY 2022
EV/EBITDA -0.1×
FY 2013: -28.2×FY 2014: -26.7×FY 2015: -7.1×FY 2016: -1.9×FY 2017: -1.3×FY 2018: -15.7×FY 2019: -1.1×FY 2020: -0.2×FY 2021: -0.3×FY 2022: -0.1×
FY 2013 5y median -0.3× FY 2022
EV/Sales 0.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2013 5y median 0.0× FY 2022
FCF Yield -206.7%
FY 2013: -3.3%FY 2014: -4.4%FY 2015: -14.0%FY 2016: -29.4%FY 2017: -15.7%FY 2018: -29.7%FY 2019: -54.7%FY 2020: -38.2%FY 2021: -77.5%FY 2022: -206.7%
FY 2013 5y median -54.7% FY 2022

Profitability

Gross Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
ROE -782.6%
FY 2013: 394.0%FY 2014: -260.2%FY 2015: -153.1%FY 2016: -132.4%FY 2017: 2113.3%FY 2018: 73.0%FY 2019: -369.5%FY 2020: -64.7%FY 2021: -82.1%FY 2022: -782.6%
FY 2013 5y median -82.1% FY 2022
ROIC -729.0%
FY 2013: 598.7%FY 2014: -260.5%FY 2015: -153.5%FY 2016: -100.5%FY 2017: -82.7%FY 2018: 276.2%FY 2019: -248.9%FY 2020: -59.7%FY 2021: -81.1%FY 2022: -729.0%
FY 2013 5y median -81.1% FY 2022
ROA -249.9%
FY 2013: -1705.1%FY 2014: -178.7%FY 2015: -121.0%FY 2016: -80.2%FY 2017: -148.9%FY 2018: 15.3%FY 2019: -101.2%FY 2020: -49.2%FY 2021: -66.1%FY 2022: -249.9%
FY 2013 5y median -66.1% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 FY 2022
Operating Income -11.0%
FY 2013: -34.1%FY 2014: 3.6%FY 2015: 22.1%FY 2016: 49.0%FY 2017: -3.5%FY 2018: -13.3%FY 2019: 37.3%FY 2020: -50.4%FY 2021: 23.3%FY 2022: -11.0%
FY 2013 FY 2022
EPS (diluted) -11.2%
FY 2013: -34.1%FY 2014: -4.4%FY 2015: -23.4%FY 2016: 48.7%FY 2017: -565.9%FY 2018: 103.1%FY 2019: -553.8%FY 2020: -7.5%FY 2021: 41.0%FY 2022: -11.2%
FY 2013 FY 2022
Free Cash Flow 22.1%
FY 2013: -46.0%FY 2014: -21.7%FY 2015: 33.8%FY 2016: 63.1%FY 2017: 8.7%FY 2018: 1.6%FY 2019: 16.5%FY 2020: -53.7%FY 2021: -14.8%FY 2022: 22.1%
FY 2013 FY 2022

Financial Health

Current Ratio 1.4×
FY 2013: 0.1×FY 2014: 2.6×FY 2015: 3.6×FY 2016: 4.1×FY 2017: 5.0×FY 2018: 2.3×FY 2019: 1.4×FY 2020: 4.6×FY 2021: 5.0×FY 2022: 1.4×
FY 2013 5y median 2.3× FY 2022
Quick Ratio 1.4×
FY 2013: 0.1×FY 2014: 2.6×FY 2015: 3.6×FY 2016: 4.1×FY 2017: 5.0×FY 2018: 2.3×FY 2019: 1.4×FY 2020: 4.6×FY 2021: 5.0×FY 2022: 1.4×
FY 2013 5y median 2.3× FY 2022
Debt / Equity 0.1×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.6×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA 0.3×
FY 2013: 0.0×FY 2014: 0.3×FY 2015: 0.1×FY 2016: 0.6×FY 2017: 0.5×FY 2018: 7.4×FY 2019: 0.5×FY 2020: 1.7×FY 2021: 1.2×FY 2022: 0.3×
FY 2013 5y median 1.2× FY 2022
Interest Coverage -166×
FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -105×FY 2021: -4032×FY 2022: -166×
FY 2013 5y median -105× FY 2022

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2013 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31